You have 9 free searches left this month | for more free features.

Chronic hepatics C virus (HCV) genotype 1

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (TG-2349, DAG181, Ribavirin)

Completed
  • Chronic Hepatics C Virus (HCV) Genotype 1
  • +3 more
  • Beijing, China
    Beijing Tsinghua Changgung Hospital
Feb 2, 2021

Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (non-cirrhotic subjects. low TG-2349+ low

Completed
  • Chronic Hepatics C Virus (HCV) Genotype 1
  • +3 more
  • non-cirrhotic subjects. low TG-2349+ low DAG181+Ribavirin
  • +5 more
  • Beijing, Beijing, China
    Peking University Peoples Hospital
Feb 16, 2021

Occult Hepatitis C Virus Infection in Patients Born Before 1969

Not yet recruiting
  • Hepatitis C, Chronic
  • +2 more
  • Meridan Bioscience Point of Care test against HCV antibodies
  • (no location specified)
Apr 2, 2023

Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

Recruiting
  • Chronic Hepatitis C Virus
  • +4 more
  • Bucuresti, BUC, Romania
    Atea Study Site
Jun 15, 2023

Zepatier in Patients With Substance Use

Active, not recruiting
  • Hepatitis C
  • +3 more
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 28, 2022

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

Active, not recruiting
  • Chronic Hepatitis
  • Hepatitis C Infection
  • Electroporation-Mediated Plasmid DNA Vaccine Therapy
  • +4 more
  • Jacksonville, Florida
  • +4 more
Sep 20, 2022

Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

Completed
  • Chronic Hepatitis C Virus (HCV) Infection
  • (no location specified)
Jul 14, 2021

Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)

Completed
  • Hepatitis C, Chronic
  • Opioid-use Disorder
  • Pittsburgh, Pennsylvania
    Magee Womens Hospital of UPMC
Aug 19, 2022

Hepatitis C Trial in Seoul

Completed
  • Hepatitis C
    • Seoul, Korea, Republic of
      Local Institution
    Jan 6, 2022

    Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

    Completed
    • Hepatitis C Virus Infection
    • +3 more
    • ABT-493 coformulated with ABT-530
    • (no location specified)
    Jul 9, 2021

    Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))

    Completed
    • Chronic Hepatitis C Virus Infection
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

    Completed
    • Chronic Hepatitis c Genotype 1
    • Moscow, Russian Federation
    • +4 more
    Oct 27, 2022

    Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

    Completed
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
    • Phoenix, Arizona
    • +47 more
    Jun 27, 2022

    HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)

    Recruiting
    • HCV
    • Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
    • Cairo, Egypt
      Faculty of Medicine, Ain-Shams University Research Institute-Cli
    May 2, 2023

    Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy Trial in Bergen, Stavanger (Health care delivery)

    Active, not recruiting
    • Hepatitis C, Chronic
    • Opioid Dependence, on Agonist Therapy
    • Health care delivery
    • Bergen, Hordaland, Norway
    • +1 more
    Aug 5, 2022

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • ABT-450/r/ABT-267, ABT-333
    • Ribavirin (RBV)
    • (no location specified)
    Jul 8, 2021

    Glecaprevir/Pibrentasvir in Chronic Hepatitis C Genotypes 1 to 6

    Completed
    • Hepatitis C Virus (HCV)
      • Makhachkala, Dagestan, Respublika, Russian Federation
      • +7 more
      Jun 23, 2022

      Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12

      Active, not recruiting
      • Hepatitis C Virus (HCV)
        • Chelyabinsk, Russian Federation
        • +9 more
        Mar 1, 2022